Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of intravenous levofloxacin in ICU patients with normal renal function vs renal hyperfiltration
2010-019691-70Phase 3Completed
- Sponsor
- Ghent University
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of levofloxacin in bacterial disease (2 arms), sponsored by Ghent University. Primary endpoints: Cmax of levofloxacin, AUC of levofloxacin and 1 more. Started Apr 2010; status: completed.
02
Drugs
levofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2010-019691-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019691-70.